09 November 2020
Today, we are delighted to announce the appointment of Dr Mana Liao as Director of the MRFF-funded $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, based in Sydney.
Mana will work with TTRA Senior Director Lauren Kelly to support management and delivery of all aspects of the TTRA program including engagement with stakeholders, project management of awarded research projects, and overall program monitoring, evaluation and reporting obligations.
Mana holds a Bachelor of Science (Molecular Biology and Genetics) from the University of Sydney, a Ph.D. in Medicine from the University of New South Wales and a Masters of Intellectual Property from University of Technology Sydney. Mana’s post-doctoral research, at the Garvan Institute, involved identification and validation of novel drug targets for diabetes and obesity.
Please join us in wishing her a warm welcome & reach out to connect with her today.